Photodynamic therapy using methyl 5-aminolevulinate (MAL) as a precursor of the photosensitizing agent protoporphyrin IX is widely used in clinical practice for the treatment of different pathologies, including cancer. In this therapeutic modality, MAL treatment promotes the forced accumulation of the endogenous photoactive compound protoporphyrin IX in target malignant cells. Subsequent irradiation of treated tissues with an appropriate visible light source induces the production of reactive oxygen species (ROS) that, once accumulated above a critical level, promote cell death. Here we demonstrate that a photodynamic treatment with low MAL concentrations can be used to promote a moderate production of endogenous ROS, which efficiently stimulates cell growth in human immortalized keratinocytes (HaCaT). We also show that this proliferative response requires Src kinase activity and is associated to a transient induction of cyclin D1 expression. Taken together, these results demonstrate for the first time that a combination of light and a photoactive compound can be used to modulate cell cycle progression through Src kinase activation and that a moderate intracellular increase of photogenerated ROS efficiently stimulates cell proliferation.
INTRODUCTION
Photodynamic therapy (PDT) is an efficient clinical approach for the treatment of different types of cancer and other pathologies (Juarranz et al., 2008 , Dolmans et al., 2003 . This therapeutic modality is based on the combination of three elements: light, oxygen and a photosensitizer (PS). Once incorporated into target cells and during irradiation with an adequate light source, the PS absorbs photons of a specific wavelength and transfers the excitation energy to the molecular oxygen contained in the cell, giving rise to a range of highly reactive oxygen species (ROS), mainly singlet oxygen ( 1 O 2 ) (Dolmans et al., 2003 , Juarranz et al., 2008 . Raising ROS levels above a critical threshold irreversibly results in cell death (Buytaert et al., 2007 , Oleinick et al., 2002 . A critical step for an efficient PDT is the selective or enhanced accumulation of the PS in target cells. This process mainly relies on the specific chemical properties of the PS and on the altered metabolism of target cells in relation to the chemical properties of the PS (Juarranz et al., 2008) . 5-Aminolevulinic acid (ALA) and its derivative methyl aminolevulinate (MAL) are the photosensitizing precursor agents most widely used in clinical practice (Kloek and Beijersbergen van, 1996 , Kennedy et al., 1990 , Casas and Batlle, 2002 . These compounds are not PSs per se but metabolic precursors of the natural PS, protoporphyrin IX (PpIX). Incorporation of ALA or MAL to mammalian cells promotes the entry of both compounds in the heme biosynthetic pathway, resulting in an increased intracellular accumulation of PpIX susceptible to act as an endogenous PS (Kloek and Beijersbergen van, 1996 , Kennedy et al., 1990 , Casas and Batlle, 2002 .
Experimental evidence obtained in the last years suggests that eukaryotic cells produce small amounts of ROS as part of different signal transduction pathways involved in cell survival and proliferation (Bartosz, 2009 , Droge, 2002 , Thannickal and Fanburg, 2000 , Kamata and Hirata, 1999 .
Although the basic molecular mechanisms underlying these effects are largely unknown, it is assumed that most physiological effects of ROS are exerted through their interaction with critical intracellular thiols in cysteine residues of different proteins (Winterbourn and Hampton, 2008 , Kamata and Hirata, 1999 , Thannickal and Fanburg, 2000 . Of particular importance are protein phospatases belonging to the cysteine-dependent phosphatase family, including classical protein tyrosine phosphatases (PTPs) and the lipid phosphatase PTEN, which have a critical cysteine residue in the catalytic site that is reversibly modified by fluctuating ROS concentrations. Thus, phosphatase function can be regulated by a delicate redox balance between ROS and the intracellular thiol pool (Chiarugi and Cirri, 2003 , Ostman and Bohmer, 2001 , Winterbourn and Hampton, 2008 . This fact has been demonstrated for PTP inhibition induced by ROS during cellular signalling from receptor tyrosine kinases (Lee and Esselman, 2002, Chiarugi and Cirri, 2003) .
In this context, recent results indicate that Src family kinases are also redoxregulated proteins (Giannoni et al., 2010) . Src kinases function can be regulated by ROS either indirectly, through inhibition of specific PTPs, or directly, through redox-dependent modification of several cysteine residues that can constitutively activate protein kinase function (Giannoni et al., 2010) . It is well known that Src family kinases are key homeostatic modulators in different tissues and physiological situations through the regulation of numerous cellular functions, including cell growth and survival, cell shape, adhesion and motility (Yeatman, 2004) . The relevance of Src family kinases for the cellular physiology highlights the potential applicability of a regulatory mechanism acting on these proteins by a controlled modulation of intracellular ROS concentrations.
Here we have used immortalized human keratinocytes to explore the ability of PDT with MAL to stimulate cell growth in vitro in a finely tuned way.
Our results show for the first time that PDT with MAL can efficiently induce cell proliferation through a tightly controlled and reproducible process that requires Src kinase activity and cyclin D1 expression and that it is not associated to genetic or cytotoxic damage.
MATERIALS AND METHODS

Cell culture and photodynamic treatments
HaCaT immortalized human keratinocytes were grown in Dulbecco´s Modified Eagle´s Medium (DMEM, Gibco) supplemented with bovine foetal serum (FBS 10%, Gibco), and 0.5% antibiotics (penicilline G [10000 U/ml] and streptomycin sulphate [10000 µg/ml] (Gibco) at 37ºC in a 5% CO 2 atmosphere. . After treatments, fresh DMEM was added to the cells.
Quantification of protoporphyrin IX biosynthesis and intracellular ROS production
Cells growing at 50%-60% confluence were incubated for 5 hours with different MAL concentrations, collected and fixed with 3.7% aqueous formaldehyde solution for 15 minutes at room temperature (RT). Once washed and resuspended in PBS, cells were assayed for PpIX fluorescence in a flow cytometer (Cytomics FC500, Beckman Coulter) exciting at 620 nm and recording at 670 nm. 20.000 cells were measured for each condition (Uehlinger et al., 2000) . Also, living cells on glass coverslips (Menzel-Gläser) were incubated with different MAL concentrations and evaluated for PpIX emission ( exc = 546 nm) using a fluorescence microscope (Olympus BX-UCB).
Quantification of ROS production was performed as described (Daghastanli et al., 2008 Sigma) at 37º C. Cells were washed and resuspended in PBS and cyclin D1 expression level was measured by flow cytometry using a 488 nm excitation line. 20.000 cells were counted in each experiment.
Genotoxic damage quantification
For the evaluation of genotoxic damage, cells were grown on coverslips, subjected to different photodynamic treatments, and fixed with 3.7%
formaldehyde in PBS. The TUNEL assay (Gavrieli et al., 1992) was used to determine the appearance of strand breaks in the DNA molecule after PDT with MAL. Cell samples were processed following the instructions of the manufacturer (Roche). The formation of phosphorylated histone H2AX (pH2AX) foci on the chromatin fibre in response to genotoxic injury (Yuan et al., 2010) was determined by immunofluorescence or immunoblot analysis using a specific mouse monoclonal anti-phosphoH2AX and H3 antibodies (Abcam) following described procedures (Espada et al., 2009 ). The % of positive cells for either TUNEL or pH2AX assays after PDT with different MAL concentrations was quantified for a sample size of 100-200 cells in two different experiments.
Inhibition of Src kinase and NOX activities and depletion of intracellular
ROS accumulation
The specific Src kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(tbutyl)pyrazolo [3,4-d] pyrimidine (PP2; Sigma) (Zhang et al., 2008) was used at 5 M in DMEM; the NOX inhibitor diphenyleneiodonium chloride (DPI; Sigma) (Ranjan et al., 2006 ) was used at 1 M in DMEM. Cells were incubated with both compounds for 5 hours and subjected to PDT with MAL. Stock solutions of both compounds were made in DMSO. Cell cultures treated with DMSO were used as control samples.
To remove intracellular ROS produced during PDT, cells were treated with the antioxidant singlet oxygen scavenger 1,4-diazabicyclo[2.2.2]octane (DABCO; Sigma) at 10 -3 M for 1 hour before PDT.
Statistical analysis
The numerical treatment of results was done with the SPSS 15.0 software package (SPSS Inc., IBM, Chicago, IL, USA). Both t-Student and Analysis of Variance (ANOVA) tests were employed to evaluate statistical significance of results.
RESULTS
Moderate PpIX-dependent intracellular ROS photogeneration efficiently stimulates cell proliferation
We have previously established two PDT protocols for skin keratinocytes designed to obtain different and defined cellular responses: a lethal condition (1 mM photosensitizer) that promotes a fast and severe cell death response by necrosis and a sublethal condition (0.5 mM photosensitizer) that promotes a delayed cell death response after activation of an E-cadherin dependent apoptotic program (Espada et al., 2009 , Galaz et al., 2005 ). Here we have tested a milder condition, 0.1 mM MAL, to evaluate potential photoactivating effects of PDT on cell proliferation.
First we analyzed the production rate of the endogenous photosensitizer PpIX after MAL treatments at different concentrations and the photoproduction rates of ROS after PDT using MAL at the indicated concentrations. When PpIX production was measured, cell cultures were exposed to MAL but were not subsequently irradiated with red light, preventing both photodynamic damage and PpIX photobleaching. The characteristic red fluorescent emission under 546 nm light irradiation was used to quantify PpIX production. For ROS production quantification, cells were exposed to MAL and then irradiated with red light to induce the photodynamic action and subsequent photodamage. The oxidized DCF fluorescent probe was used to trace ROS formation. Intracellular ROS localization and PpIX rate of synthesis were evaluated in fixed samples by flow cytometry, as well as by fluorescence microscopy in living cells after different MAL treatments.
As expected, we found a correlative MAL-dose dependent production of PpIX and ROS in HaCaT cells after PDT. A strong induction of both compounds was observed after 0.5 and 1 mM MAL treatments (Fig. 1A) . Interestingly, a moderate but statistically significant increase of endogenous ROS levels was also observed after 0.1 mM treatments (Fig. 1A) . In agreement with these observations, we observed that, as compared to non-treated cells, a low and diffuse cytoplasmic PpIX red signal was detected in HaCaT cells after MAL 0.1 mM conditions which strongly increased in the cytoplasm and accumulated in the cell membrane in cells after MAL 0.5 or 1 mM conditions ( We next evaluated the biological potential of the moderate ROS increase induced by PDT with MAL 0.1 mM treatment to modulate cell proliferation in
HaCaT cells. We found that this low increase of intracellular ROS levels promoted by 0.1 mM MAL phototreatments was sufficient to induce a significant and reproducible increment of the mitotic index in HaCaT cells (Fig. 1C) associated to an acute increase of the S-phase cell population 24 hours after the treatment (Fig. 1D) . No mitogenic effects were observed when cells were treated with MAL in the absence of red light or with red light in the absence of MAL (Fig. 1C, D) . Notably, we have also found that the mitogenic effect of PDT with MAL on HaCaT cells was strongly enhanced by a two-step sequential photodynamic treatment (Fig. 2) . Thus, a second 0.1 mM MAL treatment 48
hours after the first one resulted in a statistically significant increase at 72 hours of a roughly 10% in the number of viable cells as compared to samples stimulated by a single treatment (Fig. 2) . It is to note that in this experiment the mitotic index ratio decreased between 24 and 48 hours while the number of viable cells increased (Fig. 2) . However, although the mitotic index ratio decreased between 24h and 48 hours, it actually did not returned to 0 values.
Instead, it steadily returned to a background level in which the mitotic ratio of treated samples is the same as that of non-stimulated, normal proliferating controls. This implies that, between 24 and 48h, PDT treated samples still present higher mitotic ratios than controls. In these conditions, given a previously higher number of viable cells and a higher mitotic ratio as compared to controls, a steady increase in the number of viable cells in treated samples was observed (Fig. 2) . In this context, our results indicate that a second PDT treatment at 48 hours can hold back the declining trend of the mitotic ratio, promoting a new increase at 72 hours, which result in a concomitant and additional increase in the number of viable cells (Fig. 2) . As a whole, these results demonstrate that a combination of red light and increased levels of PpIX, resulting in a moderate production of intracellular ROS, can be used to stimulate cell growth.
PpIX-dependent photodynamic stimulation of cell proliferation does not promote genotoxic or cytotoxic damage
Treatment of cultured cells with an exogenous ROS source, such as H 2 O 2 , can promote a moderate increase of cell proliferation but also extensive and/or irreversible cell damage (Pryor et al., 2006) . To discard deleterious effects induced by PDT with 0.1 mM MAL, we investigated potential genotoxic or cytotoxic damage using different approaches.
We first evaluate the incidence of PDT with MAL on cell viability using the MTT assay. We found no significant effects of PDT with 0.1 mM MAL on cell survival at either the standard 10 minutes red light irradiation time or at longer irradiation times up to 30 minutes (Fig. 3A) . By contrast, PDT with 0.5 or 1 mM MAL resulted in a significant cytotoxic effect with 10 minutes irradiation time, greatly increased with longer irradiation times (Fig. 3A) . This result is in close agreement with our observations regarding the effects on cell morphology of PDT with different MAL concentrations (Fig. 1B) .
We next analyzed potential genotoxic effects of PDT with 0.1 mM MAL by the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay to detect DNA breaks (Gavrieli et al., 1992) or by detection of extended phosphorylated histone H2AX (pH2AX) foci formation on the chromatin fibre associated to severe DNA damage (Yuan et al., 2010) . Interestingly, a strong increase of pH2AX nuclei was observed by immunofluorescence and immunoblot analysis in apoptotic 0.5 mM MAL treated cells, but not in viable 0.1 mM MAL treated cells or necrotic 1 mM treated cells (Fig. 3B, C, D ). This result demonstrate that the pH2AX signal of genomic damage was triggered by 0.5 mM sub-lethal treatments but not by stimulating 0.1 mM conditions and indicated that the necrotic nuclei caused by 1 mM treatments were also unable to trigger a pH2AX-dependent response to genomic damage. Likewise, our results showed that, as expected, PDT with 0.5 or 1 mM MAL induced a strong DNA fragmentation revealed by TUNEL assay (Fig. 3B, D) . In sharp contrast, no such damaging effects were observed after PDT with 0.1 mM MAL (Fig. 3B,   D) . As a whole, these results indicate that PDT with 0.1 mM MAL is a cellularsafe process to stimulate cell proliferation in the absence of cytotoxic or genotoxic side effects.
PpIX-dependent photodynamic stimulation of cell proliferation requires ROS production and it is associated with an increase in cyclin D1 expression
To elucidate the molecular basis underlying the stimulation of cell proliferation by PDT with MAL, we first analyze the requirement of ROS in this process. To this end, cells subjected to PDT with 0.1 mM MAL were treated during light irradiation with the antioxidant DABCO, a known 1 O 2 scavenger that efficiently blocks intracellular effects of ROS increase. We found that DABCO completely inhibited the stimulatory effect of PDT with MAL on cell proliferation without noticeable effects on cell viability (Fig. 4A ). This result demonstrates that photostimulation of cell proliferation with MAL mainly relies on a moderate increase of intracellular ROS.
We hypothesized that the increase of the mitotic index and the induction of cell proliferation after PDT with MAL was necessarily associated to a concomitant expression of cell cycle regulatory proteins. To corroborate this idea we carried out a time course analysis of cyclin protein expression after cell photoactivation with MAL. In particular, we found a strong and transient increase of cyclin D1 protein levels between 3 to 8 hours after PDT with MAL in
HaCaT cells ( Figure 4B ). The expression of cyclin D1 induced after PDT with MAL was completely inhibited by intracellular ROS scavenging with DABCO.
These results indicate that cell proliferation induced by PDT with MAL is associated to a transient increase in cyclin D1 expression which depends on ROS production.
PpIX-dependent photodynamic stimulation of cell proliferation and transient cyclin D1 expression depends on Src kinase activity
It is well known that Src kinases can regulate cell cycle progression through activation of cyclin D1 expression (Sinibaldi et al., 2000 , Leslie et al., 2006 . It has also become clear in the last years that Src kinases are regulated by intracellular ROS (Giannoni et al., 2010) . In this context, we reasoned that the activity of Src kinase was probably implicated in the stimulation of cell proliferation and in the concomitant transient activation of cyclin D1 after PDT with 0.1 mM MAL. To evaluate this hypothesis, we performed a series of photoactivation experiments using our established MAL-dependent conditions to stimulate cell proliferation in the presence or absence of the specific Src kinase inhibitor PP2. Our results clearly showed that, as compared to control samples, Src kinase activity inhibition had no effect on cell viability but significantly blocked the induction of cell proliferation promoted by PDT with 0.1 mM MAL (Fig. 5A ). In the same way, we also observed that Src kinase inhibition completely aborted the transient cyclin D1 expression that we had observed to be associated to PDT with 0.1 mM MAL (Fig. 5B ). Taken as a whole, these results suggest that cell proliferation stimulation after PDT with 0.1 mM MAL on
HaCaT cells is a direct result of a transient expression of cyclin D1 induced by
Src kinase activity.
The mitochondria are important foci of intracellular ROS production.
However, mitochondrial ROS production has mainly to do either with inefficient electron leakage to molecular oxygen during aerobic respiration, or with specific signaling for the initiation and promotion of apoptotic processes. It is now widely accepted that NOX activity is the main source of physiological ROS involved in cell signaling through interaction with specific components of cell signaling pathways (Nohl et al., 2005 , Raddatz et al., 2011 , Brown and Borutaite, 2011 . In this context, we also wanted to evaluate the effect of NOX enzymatic inhibition on the stimulatory effect of PDT with 0.1 mM MAL. To this end, we used the NOX inhibitor DPI in PDT with 0.1 mM MAL experiments. Our results showed that, as compared to control samples, inhibition of NOX activity did not affected neither cell proliferation or viability, nor cyclin D1 expression induced by PDT with 0.1 mM MAL (Fig. 5A, B) , indicating that the production of endogenous ROS in this process is independent of NOX activity.
DISCUSSION
The possibility to stimulate cell proliferation using light and an endogenous photoactive compound is a provocative approach that can have a broad range of applications from biotechnology to regenerative medicine. In this study we report the stimulation of cell proliferation in immortalized human keratinocytes after a mild photodynamic treatment which is strongly enhanced by a sequential two-step protocol. We have demonstrated that the induction of cell proliferation by PDT with MAL is mediated by singlet oxygen production induced by PpIX photodynamic activation; this cell stimulation is associated to a transient upregulation of cyclin D1 expression and depends on Src kinase activity.
The Cyclin family of cell cycle regulator proteins has been identified as an important target in the redox-dependent regulation of cell cycle progression.
In particular, it is known that exogenous ROS can regulate cyclin D1 levels through the modulation of classical tyrosine phosphatase activity (Ranjan et al., 2006 , Martinez Munoz et al., 2001 , Burch and Heintz, 2005 and can also modify the proteasome-dependent metabolic degradation balance of cyclin D1 through a redox-dependent pathway (Martinez Munoz et al., 2001 ). In the same way, it has been reported that overexpression of catalase decreases the transition from G 1 to S in a cyclin D1-mediated mechanism (Onumah et al., 2009 ). In agreement with these observations, the results presented here indicate that a moderate endogenous ROS production can rapidly promote a transient increase in cyclin D1 expression. As a whole, these observations point to the evidence of an extended redox mechanism for the synchronized generation of ROS during cell cycle in mammalian cells that is implicated in the regulation of cyclin D1 expression (Menon and Goswami, 2007 , Burch and Heintz, 2005 , Takahashi et al., 2004 .
It has been shown that exposure of different mammalian cell types to an exogenous source of ROS results in the phosphorylation and activation of large number of signalling molecules implicated in cell cycle regulation, including receptor tyrosine kinases, PKC, PKB, Src kinase PLC1 and MAPKs (Boonstra and Post, 2004) . In the same way, different studies indicate that different ligands, including TNF , TGF 1, interleukin1, PDGF and EGF can promote a receptor activation-dependent increase of ROS (Boonstra and Post, 2004) . In this context, our results using a PDT approach can be considered as an additional proof of concept for the more general idea that a moderate and transient endogenous ROS production can stimulate cell proliferation (Menon and Goswami, 2007 , Takahashi et al., 2004 , Boonstra and Post, 2004 ).
At present, it is accepted that the main source of intracellular ROS for cell signalling is the result of the activity of the NADPH-oxidase (NOX) protein family (Bedard and Krause, 2007, Chan et al., 2009 ). Here we have shown that stimulation of cell proliferation by PDT with MAL requires ROS production but it is independent of NOX activity. Since the main ROS source during PDT with MAL is PpIX, this is an expected result and reinforces the view that regulating the biosynthetic production of PpIX by dosing the given amount of MAL is a valuable tool to modulate the production of endogenous ROS to obtain different cellular responses. On the other side, our results have also shown that stimulation by PDT with MAL entirely depends on Src kinase activity. Taking into account that Src kinase can be constitutively activated by intracellular ROS (Giannoni et al., 2010) and that cyclin D1 is a target of Src kinase activity (Leslie et al., 2006 , Yeatman, 2004 , Sinibaldi et al., 2000 , our results reinforce the emerging concept of the regulation of intracellular ROS balance as an important cell signalling mechanism.
In conclusion, the results reported here demonstrate for the first time that red light in combination with an appropriate photosensitizer can be used to manipulate the cell cycle activity at a specific point by the punctual photogeneration of signaling ROS. As a rule, eukaryotic cells present the least reduced cytoplasmic environment during the first half of the G 1 phase of the cell cycle (Winterbourn and Hampton, 2008) . During this period there exists an optimum ROS stimulating window, during which the cell can efficiently respond to peaks of transient endogenous ROS production. Once the cell is committed to enter the cell cycle, mainly through cyclin D1 upregulation, the cytoplasm adopts a reducing trend in its redox status that makes it refractory to any further ROS signaling until the cell completes the M phase (Menon and Goswami, 2007) . In this context, it can be hypothesized that photostimulation of cell proliferation after mild MAL treatments specifically affects cells that are in the early and middle G 1 phase. This experimental approach opens the possibility to photostimulate tissues to improve its homeostatic response in processes such as wound healing and organ repair. 
